Observational studyBreast cancer research and treatment2014

Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study.

Patrizia Vici et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.